Literature DB >> 28369673

Neurological toxicities and coagulation disorders in the cytokine release syndrome during CAR-T therapy.

Heng Mei1,2, Huiwen Jiang1,2, Yaohui Wu1,2, Tao Guo1,2, Linghui Xia1,2, Runming Jin1,3, Yu Hu1,2.   

Abstract

Entities:  

Keywords:  central nervous system; chimeric antigen receptor-T therapy; coagulation; cytokine release syndrome

Mesh:

Substances:

Year:  2017        PMID: 28369673     DOI: 10.1111/bjh.14680

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  18 in total

Review 1.  Are chimeric antigen receptor T cells (CAR-T cells) the future in immunotherapy for autoimmune diseases?

Authors:  Yeison Santamaria-Alza; Gloria Vasquez
Journal:  Inflamm Res       Date:  2021-05-20       Impact factor: 4.575

Review 2.  CAR T Cell Therapy for Hematological Malignancies.

Authors:  Xin Yang; Gao-Xiang Wang; Jian-Feng Zhou
Journal:  Curr Med Sci       Date:  2019-12-16

3.  Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features.

Authors:  Xian Zhang; Xin-An Lu; Junfang Yang; Gailing Zhang; Jingjing Li; Lisong Song; Yunchao Su; Yanze Shi; Min Zhang; Jiujiang He; Dan Song; Fanyong Lv; Wenqian Li; Yan Wu; Hui Wang; Hongxing Liu; Xiaosu Zhou; Ting He; Peihua Lu
Journal:  Blood Adv       Date:  2020-05-26

4.  Mapping the stochastic sequence of individual ligand-receptor binding events to cellular activation: T cells act on the rare events.

Authors:  Jenny J Y Lin; Shalini T Low-Nam; Katherine N Alfieri; Darren B McAffee; Nicole C Fay; Jay T Groves
Journal:  Sci Signal       Date:  2019-01-15       Impact factor: 8.192

Review 5.  Bispecific Antibodies: A Review of Development, Clinical Efficacy and Toxicity in B-Cell Lymphomas.

Authors:  Ross Salvaris; Jeremy Ong; Gareth P Gregory
Journal:  J Pers Med       Date:  2021-04-29

Review 6.  Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies.

Authors:  Shangjun Sun; He Hao; Ge Yang; Yi Zhang; Yang Fu
Journal:  J Immunol Res       Date:  2018-04-17       Impact factor: 4.818

Review 7.  Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma.

Authors:  Tiantian Ma; Jing Shi; Huasheng Liu
Journal:  Ann Hematol       Date:  2019-01-28       Impact factor: 3.673

Review 8.  Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy.

Authors:  Zhenguang Wang; Weidong Han
Journal:  Biomark Res       Date:  2018-01-22

Review 9.  Cytokine release syndrome.

Authors:  Alexander Shimabukuro-Vornhagen; Philipp Gödel; Marion Subklewe; Hans Joachim Stemmler; Hans Anton Schlößer; Max Schlaak; Matthias Kochanek; Boris Böll; Michael S von Bergwelt-Baildon
Journal:  J Immunother Cancer       Date:  2018-06-15       Impact factor: 13.751

Review 10.  The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy.

Authors:  Dongfang Liu; Saiaditya Badeti; Gianpietro Dotti; Jie-Gen Jiang; He Wang; James Dermody; Patricia Soteropoulos; Deanna Streck; Raymond B Birge; Chen Liu
Journal:  Cell Commun Signal       Date:  2020-08-25       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.